Duration of Action of Beta-blocking Drugs
Overview
Affiliations
The assessment of β-adrenoceptor blocking drugs in hyperthyroidism.
Carruthers S, Ghosal A, McDevitt D, Nelson J, Shanks R Br J Clin Pharmacol. 2012; 1(2):93-8.
PMID: 22454894 PMC: 1402445. DOI: 10.1111/j.1365-2125.1974.tb00216.x.
Himori N, Honma S, Izumi A, Ishimori T Naunyn Schmiedebergs Arch Pharmacol. 1981; 316(1):19-23.
PMID: 6116195 DOI: 10.1007/BF00507221.
Propranolol in the control of schizophrenic symptoms.
Yorkston N, Zaki S, Malik M, MORRISON R, Havard C Br Med J. 1974; 4(5945):633-5.
PMID: 4441828 PMC: 1612952. DOI: 10.1136/bmj.4.5945.633.
New approach to assessment of cardioselectivity of beta-blocking drugs.
Kumana C, Marlin G, Kaye C, Smith D Br Med J. 1974; 4(5942):444-7.
PMID: 4425917 PMC: 1612509. DOI: 10.1136/bmj.4.5942.444.
Kumana C, Kaye C Eur J Clin Pharmacol. 1974; 7(4):243-8.
PMID: 4152776 DOI: 10.1007/BF00560338.